Bridgebio Oncology Therapeutics, Inc. (BBOT)
1.82
-0.04
(-2.15%)
USD |
NASDAQ |
Nov 20, 10:47
Bridgebio Oncology Therapeutics Free Cash Flow : -151.03M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -151.03M |
| June 30, 2026 | -193.82M |
| March 31, 2026 | -172.93M |
| December 31, 2025 | -156.75M |
| Date | Value |
|---|---|
| September 30, 2025 | -129.49M |
| June 30, 2025 | -97.71M |
| March 31, 2025 | -74.22M |
| December 31, 2024 | -55.08M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Korsana Biosciences, Inc. | -51.31M |
| IRulya Therapeutics, Inc. | -46.91M |
| PepGen Inc. | -63.28M |
| Q32 Bio, Inc. | -20.07M |
| Oncolytics Biotech, Inc. | -28.39M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -28.36M |
| Cash from Investing (Quarterly) | 50.34M |
| Cash from Financing (Quarterly) | 0.442M |
| Free Cash Flow Per Share (Quarterly) | -0.3539 |
| Free Cash Flow to Equity (Quarterly) | -28.24M |
| Free Cash Flow to Firm (Quarterly) | -28.38M |
| Free Cash Flow Yield | -103.4% |